Cetera Advisor Networks’s Novavax NVAX Stock Holding History

Cetera Advisor Networks’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,227	Closed	-$147K	–	2680
2023 Q1	$147K	Buy	21,227 +4,775	+29%	+$43.9K	﹤0.01%	2386
2022 Q4	$169K	Sell	16,452 -25	-0.2%	-$441	﹤0.01%	2303
2022 Q3	$300K	Buy	16,477 +1,714	+12%	+$74.3K	﹤0.01%	1600
2022 Q2	$759K	Buy	14,763 +6,826	+86%	+$354K	0.01%	1027
2022 Q1	$585K	Buy	7,937 +2,480	+45%	+$221K	0.01%	1206
2021 Q4	$781K	Buy	5,457 +2,161	+66%	+$371K	0.01%	1018
2021 Q3	$683K	Buy	3,296 +1,068	+48%	+$235K	0.01%	1028
2021 Q2	$473K	Buy	+2,228	New	+$408K	0.01%	1210
2020 Q3	–	Sell	-300	Closed	-$25K	–	2423
2020 Q2	$25K	Buy	+300	New	+$11.5K	﹤0.01%	2277

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cetera Advisor Networks's NVAX Position: Q2 2023 in Review

Cetera Advisor Networks sold out of Novavax (NVAX) in Q2 2023, closing a stake of 21,227 shares — an estimated $147K sold.

Cetera Advisor Networks first reported a position in NVAX in Q2 2020 and held it in 9 quarters. The position peaked at $781K in Q4 2021. 215 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

Cetera Advisor Networks reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
Cetera Advisor Networks sold 21,227 Novavax shares in Q2 2023, an estimated $147K.
Cetera Advisor Networks first reported a position in Novavax in Q2 2020 and held it in 9 quarters.
Cetera Advisor Networks's Novavax position peaked at $781K in Q4 2021.
215 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on Cetera Advisor Networks's 13F filing for Q2 2023, filed 10 Aug 2023.